{
    "title": "Strong vaccine sales give Glaxo a shot in the arm",
    "url": "https://www.dailymail.co.uk/money/markets/article-12342019/Strong-vaccine-sales-Glaxo-shot-arm.html",
    "date": "2023-07-26",
    "keywords": [
        "cent",
        "share",
        "arm",
        "year",
        "boost",
        "fund",
        "gsk",
        "walmsley",
        "shot",
        "profit",
        "quarter",
        "glaxosmithkline",
        "executive",
        "hiv",
        "product",
        "glaxo",
        "approval",
        "haleon",
        "vaccine",
        "rsv",
        "claimant",
        "price",
        "month",
        "investment",
        "account",
        "fee",
        "boss",
        "emma",
        "drugsthe",
        "ftse",
        "giant",
        "target",
        "previouslygsk",
        "rise",
        "jump",
        "blockbuster",
        "shingrix",
        "increase",
        "performance",
        "growth",
        "strengthening",
        "research",
        "pipeline",
        "portfolio",
        "session",
        "jab",
        "lawsuit",
        "article",
        "upgrade",
        "overhaul",
        "consumer",
        "health",
        "business",
        "debut",
        "arexvy",
        "virus",
        "runny",
        "sneezing",
        "cough",
        "citibank",
        "half",
        "stock",
        "winter",
        "company",
        "series",
        "heartburn",
        "drug",
        "zantac",
        "chemical",
        "trial",
        "california",
        "firm",
        "overhang",
        "position",
        "diy",
        "capital",
        "risk",
        "isa",
        "trade",
        "community",
        "model",
        "affiliate",
        "money",
        "commission",
        "editorial",
        "independence",
        "investing",
        "platform"
    ],
    "category": [
        "money",
        "markets"
    ]
}